Results 211 to 220 of about 322,522 (245)

Immunoglobulin therapies for primary immunodeficiency diseases (part 1): understanding the pharmacokinetics. [PDF]

Immunotherapy
Mahmood I, Li Z.
europepmc   +1 more source

Rodent monocyte‐derived macrophages do not express CD163: Comparative analysis using macrophages from living boreoeutherians

Developmental Dynamics, EarlyView.
Abstract Background CD163 is a scavenger receptor predominantly expressed on the surfaces of macrophages in various mammalian species and is a marker of anti‐inflammatory (M2‐like) macrophages. High density of CD163‐positive tumor‐associated macrophages (TAMs) is associated with worse prognosis in various patient tumors.
Yoichi Saito, Yukio Fujiwara, Yasuka L. Yamaguchi, Satomi S. Tanaka, Kyoko Miura, Yoshiyuki Hizukuri, Kyoko Yamashiro, Yasuhiro Hayashi, Yuta Nakashima, Yoshihiro Komohara   +9 more
wiley   +1 more source

Psychosocial Evaluation of Adults with Primary Immunodeficiency. [PDF]

J Clin Immunol
Gumusburun R, Altay S, Cengiz H, Hakverdioglu Yont G, Kuman Tuncel O, Ardeniz O.   +5 more
europepmc   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Primary Immunodeficiency-Type Ataxia-Telangiectasia Revealed by Splenic Abscesses. [PDF]

Cureus
Bebana A, Ghanam A, Tkak H, Elouali A, Babakhouya A, Rkain M.   +5 more
europepmc   +1 more source

Infectious Complications in Primary Immunodeficiency Patients Receiving Immunoglobulin Replacement Therapy: 5 Years Experience

Makbule Seda Bayrak Durmaz, Döne Gülçin Unutmaz Erkaya, Göksal Keskin, Seda Altıner   +3 more
openalex   +2 more sources

Albinism and Primary Immunodeficiency in Infants: A Case Study of Griscelli Syndrome. [PDF]

Cureus
Bouhafs N, N'joumi C, Elouali A, Babakhouya A, Rkain M, Benajiba N.   +5 more
europepmc   +1 more source

Approach to a child with primary immunodeficiency made simple

, 2017
Amit Rawat, Dhrubajyoti Sharma, A Jindal, Surjit Singh   +3 more
openalex   +1 more source

Dissecting Secondary Immunodeficiency: Identification of Primary Immunodeficiency within B-Cell Lymphoproliferative Disorders. [PDF]

J Clin Immunol
Palacios-Ortega M, Guerra-Galán T, Jiménez-Huete A, García-Aznar JM, Pérez-Guzmán M, Mansilla-Ruiz MD, Mendiola ÁV, López CP, Hornero EM, Rodriguez AP, Cortijo AP, Polo Zarzuela M, Morales MM, Mandly EA, Cárdenas MC, Carrero A, García CJ, Bolaños E, Íñigo B, Medina F, de la Fuente E, Ochoa-Grullón J, García-Solís B, García-Carmona Y, Fernández-Arquero M, Benavente-Cuesta C, de Diego RP, Rider N, Sánchez-Ramón S.   +28 more
europepmc   +1 more source